Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations

Sponsor
Duke University (Other)
Overall Status
Completed
CT.gov ID
NCT04496453
Collaborator
National Institutes of Health (NIH) (NIH)
17
1
1
15.3
1.1

Study Details

Study Description

Brief Summary

The purpose of this study is to develop and evaluate a tool designed to help parents make decisions about childhood vaccines.

Condition or Disease Intervention/Treatment Phase
  • Other: Childhood vaccination decision support tool
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
Actual Study Start Date :
Dec 14, 2020
Actual Primary Completion Date :
Mar 24, 2022
Actual Study Completion Date :
Mar 24, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Childhood vaccination decision support tool

Participants receive childhood vaccination decision support tool

Other: Childhood vaccination decision support tool
Participants receive childhood vaccination decision support tool

Outcome Measures

Primary Outcome Measures

  1. Change in knowledge related to childhood vaccinations [pre-survey (baseline) and post-survey (at completion of intervention, approximately 4-6 weeks after baseline)]

    Assessed using survey

  2. Change in acceptability of childhood vaccinations [pre-survey (baseline) and post-survey (at completion of intervention, approximately 4-6 weeks after baseline)]

    Assessed using survey

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least 18 years of age

  • Parent or primary caregiver of a child between the ages of 3-6 years who is receiving primary care at Duke.

  • Fluent in English

Exclusion Criteria:
  • Unable to understand the study objectives, procedures, risks, and benefits

  • Unable to consent for themselves

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Health System Durham North Carolina United States 27710

Sponsors and Collaborators

  • Duke University
  • National Institutes of Health (NIH)

Investigators

  • Principal Investigator: Lavanya Vasudevan, Ph.D., Duke University

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT04496453
Other Study ID Numbers:
  • Pro00101904
  • 1KL2TR002554
First Posted:
Aug 3, 2020
Last Update Posted:
Jul 15, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University

Study Results

No Results Posted as of Jul 15, 2022